Skip to content
OmniLead
Start free

Active biotechnology investors in Delaware — 2026

107 investors backed 11 biotechnology offerings by companies in Delaware in the last 12 months, per SEC Form D. Companies file a Form D with the SEC when they raise money under Regulation D, and report how many investors have already put money in. Funds file one too when they raise, which is how we list the venture and private equity funds based in Delaware. Figures come straight from SEC EDGAR and refresh daily.

Investors in these offerings
107
Form D “total number already invested” · All 11 offerings, Sep 28, 2025 – Sep 28, 2026
New biotechnology offerings
11
Companies in Delaware that filed a new Form D, Sep 28, 2025 – Sep 28, 2026
Amount sold
$53.6M
As reported in Form D · All 11 offerings, Sep 28, 2025 – Sep 28, 2026

Offerings are matched on the Form D industry group (Biotechnology) and the company’s business address, one offering per company, funds excluded. Each filing reports how many investors have already invested, not who they are, so an investor in two offerings counts twice. Run the same search on sec.gov.

Venture and private equity funds based in Delaware

SEC EDGAR Form D filings

Funds file a Form D when they raise from their own investors. These are recent filings by venture capital and private equity funds with a business address in Delaware, from the last 5 days, newest first.

Recent Form D filings by venture capital and private equity funds in Delaware
FundTypeCityFund sizeFiledFiling
DeepTechX Ventures Fund I, LPVenture capital fundLEWES$25.0MSep 28, 2026 · amendmentForm Dfor DeepTechX Ventures Fund I, LP on sec.gov
Bungalow SPVs Fund LLC - Series 7Venture capital fundDOVER$1.2MSep 28, 2026Form Dfor Bungalow SPVs Fund LLC - Series 7 on sec.gov
Global Horizons Holdings Ventures LLC - Series 112Venture capital fundDOVER$353.5KSep 28, 2026Form Dfor Global Horizons Holdings Ventures LLC - Series 112 on sec.gov
Decimus Defense Fund LLC - Series 14Venture capital fundDOVER$279.1KSep 28, 2026Form Dfor Decimus Defense Fund LLC - Series 14 on sec.gov
BIO FUND I a Series of FOG Ventures Fund III LLCVenture capital fundNEWARK$278.8KSep 28, 2026Form Dfor BIO FUND I a Series of FOG Ventures Fund III LLC on sec.gov
GEN AI FUND H a Series of FOG Ventures Fund III LLCVenture capital fundNEWARK$385.8KSep 28, 2026Form Dfor GEN AI FUND H a Series of FOG Ventures Fund III LLC on sec.gov
Shah Physician Syndicate Fund LLC - Series 6Venture capital fundDOVER$223.7KSep 25, 2026Form Dfor Shah Physician Syndicate Fund LLC - Series 6 on sec.gov
Kattegat Capital - SL - 2026 a Series of CGF2021 LLCVenture capital fundCLAYMONT$185.0KSep 25, 2026Form Dfor Kattegat Capital - SL - 2026 a Series of CGF2021 LLC on sec.gov
Solimar Capital Partners Funds LLC - Series 4Venture capital fundDOVER$200.0KSep 25, 2026Form Dfor Solimar Capital Partners Funds LLC - Series 4 on sec.gov
Pari Passu Master IV LLC - Series 24Venture capital fundDOVER$338.0KSep 25, 2026Form Dfor Pari Passu Master IV LLC - Series 24 on sec.gov
Antigravity Capital a Series of CGF2021 LLCVenture capital fundCLAYMONT$1.0MSep 25, 2026Form Dfor Antigravity Capital a Series of CGF2021 LLC on sec.gov

Funds with “Bio”, “Biotech”, “Biotechnology”, “Bioscience” in their name

Form D doesn’t say what a fund invests in, so this is a keyword match on the fund’s name, not a stated biotechnology focus. Venture capital and private equity funds in Delaware that filed in the last 12 months.

Funds in Delaware with a biotechnology keyword in their name
FundTypeCityFund sizeFiledFiling
BIO FUND I a Series of FOG Ventures Fund III LLCBioVenture capital fundNEWARK$278.8KSep 28, 2026Form Dfor BIO FUND I a Series of FOG Ventures Fund III LLC on sec.gov
Longevity Angels - Lento Bio Seed a Series of CGF2021 LLCBioVenture capital fundCLAYMONT$52.5KJul 2, 2026Form Dfor Longevity Angels - Lento Bio Seed a Series of CGF2021 LLC on sec.gov
Marigold Biosciences Mar 2026 a Series of CGF2021 LLCBiosciencesVenture capital fundCLAYMONT$26.0KMay 11, 2026Form Dfor Marigold Biosciences Mar 2026 a Series of CGF2021 LLC on sec.gov
Fed Bio Apr 2026 a Series of CGF2021 LLCBioVenture capital fundCLAYMONT$214.5KApr 29, 2026Form Dfor Fed Bio Apr 2026 a Series of CGF2021 LLC on sec.gov
Advantage Life Sciences I Jan 2026 a Series of CGF2021 LLCLife sciencesVenture capital fundCLAYMONT$250.0KApr 24, 2026Form Dfor Advantage Life Sciences I Jan 2026 a Series of CGF2021 LLC on sec.gov
Fairfield Bio Mar 2026 a Series of CGF2021 LLCBioVenture capital fundCLAYMONT$306.1KApr 15, 2026Form Dfor Fairfield Bio Mar 2026 a Series of CGF2021 LLC on sec.gov
Brown Angel Group Peel Therapeutics a Series of CGF2021 LLCTherapeuticsVenture capital fundCLAYMONT$125.0KApr 13, 2026Form Dfor Brown Angel Group Peel Therapeutics a Series of CGF2021 LLC on sec.gov
Retro Bio SYNC.VC SPV Feb 2026 a Series of CGF2021 LLCBioVenture capital fundCLAYMONT$271.5KMar 27, 2026Form Dfor Retro Bio SYNC.VC SPV Feb 2026 a Series of CGF2021 LLC on sec.gov
Retro Bio - Team Ignite Feb 2026 a Series of CGF2021 LLCBioVenture capital fundCLAYMONT$81.0KMar 13, 2026Form Dfor Retro Bio - Team Ignite Feb 2026 a Series of CGF2021 LLC on sec.gov
Romix Biosciences SPV a Series of CGF2021 LLCBiosciencesVenture capital fundCLAYMONT$175.0KJan 27, 2026Form Dfor Romix Biosciences SPV a Series of CGF2021 LLC on sec.gov

Organisation-level public data from SEC EDGAR. We don’t publish personal names or contact details on this page. Fund size is the offering amount in the fund’s Form D; “Indefinite” means the filing didn’t state one.

In OmniLead

From fund filings to the people who run the funds.

The Investors lens lists funds from their Form D filings with fund type, fund size and last filing date, plus the executive officers and managing members each filing names. Contacts come from the fund’s own website, with the source on every row.

Start freeTry the investor lookup

Raising in Delaware? Find investors who fit.

Search investors built from SEC Form D filings, see why each one matches your round, and reach them from your own inbox.

Start freeSee pricing